Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome.
Matsumori R, Miyazaki T, Shimada K, Kume A, Kitamura Y, Oshida K, Yanagisawa N, Kiyanagi T, Hiki M, Fukao K, Hirose K, Ohsaka H, Mokuno H, Daida H. Matsumori R, et al. Among authors: hiki m. Diabetes Res Clin Pract. 2013 Jan;99(1):12-8. doi: 10.1016/j.diabres.2012.10.025. Epub 2012 Nov 10. Diabetes Res Clin Pract. 2013. PMID: 23146370
Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area.
Yanagisawa N, Shimada K, Miyazaki T, Kume A, Kitamura Y, Ichikawa R, Ohmura H, Kiyanagi T, Hiki M, Fukao K, Sumiyoshi K, Hirose K, Matsumori R, Takizawa H, Fujii K, Mokuno H, Inoue N, Daida H. Yanagisawa N, et al. Among authors: hiki m. J Atheroscler Thromb. 2010 Mar 31;17(3):285-94. doi: 10.5551/jat.2618. Epub 2010 Mar 13. J Atheroscler Thromb. 2010. PMID: 20228612 Free article.
Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic patients with coronary heart disease (J-MACH) -.
Hiki M, Shimada K, Kiyanagi T, Fukao K, Hirose K, Ohsaka H, Fukushima Y, Kume A, Matsumori R, Sumiyoshi K, Miyazaki T, Ohmura H, Kurata T, Miida T, Daida H. Hiki M, et al. Circ J. 2010 Jul;74(7):1471-8. doi: 10.1253/circj.cj-10-0013. Epub 2010 Jun 1. Circ J. 2010. PMID: 20519875 Free article. Clinical Trial.
Voluntary exercise ameliorates the progression of atherosclerotic lesion formation via anti-inflammatory effects in apolipoprotein E-deficient mice.
Fukao K, Shimada K, Naito H, Sumiyoshi K, Inoue N, Iesaki T, Kume A, Kiyanagi T, Hiki M, Hirose K, Matsumori R, Ohsaka H, Takahashi Y, Toyoda S, Itoh S, Miyazaki T, Tada N, Daida H. Fukao K, et al. Among authors: hiki m. J Atheroscler Thromb. 2010 Dec 26;17(12):1226-36. doi: 10.5551/jat.4788. Epub 2010 Aug 27. J Atheroscler Thromb. 2010. PMID: 20808053 Free article.
Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting.
Miyazaki T, Shimada K, Miyauchi K, Kume A, Tanimoto K, Kiyanagi T, Sumiyoshi K, Hiki M, Mokuno H, Okazaki S, Sato H, Kurata T, Daida H. Miyazaki T, et al. Among authors: hiki m. Lipids Health Dis. 2010 Oct 25;9:122. doi: 10.1186/1476-511X-9-122. Lipids Health Dis. 2010. PMID: 20973966 Free PMC article. Clinical Trial.
Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation.
Masaki Y, Shimada K, Kojima T, Miyauchi K, Inoue K, Kiyanagi T, Hiki M, Fukao K, Hirose K, Ohsaka H, Kume A, Miyazaki T, Ohmura H, Ohsaka A, Daida H. Masaki Y, et al. Among authors: hiki m. J Cardiol. 2011 May;57(3):303-10. doi: 10.1016/j.jjcc.2011.01.015. Epub 2011 Mar 8. J Cardiol. 2011. PMID: 21388786 Free article.
Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between azelnidipine and amlodipine on glucose tolerance and endothelial function--a crossover trial (AGENT).
Fukao K, Shimada K, Hiki M, Kiyanagi T, Hirose K, Kume A, Ohsaka H, Matsumori R, Kurata T, Miyazaki T, Daida H. Fukao K, et al. Among authors: hiki m. Cardiovasc Diabetol. 2011 Sep 10;10:79. doi: 10.1186/1475-2840-10-79. Cardiovasc Diabetol. 2011. PMID: 21906391 Free PMC article. Clinical Trial.
Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome.
Matsumori R, Shimada K, Kiyanagi T, Hiki M, Fukao K, Hirose K, Ohsaka H, Miyazaki T, Kume A, Yamada A, Takagi A, Ohmura H, Miyauchi K, Daida H. Matsumori R, et al. Among authors: hiki m. J Cardiol. 2012 Sep;60(3):168-73. doi: 10.1016/j.jjcc.2012.03.008. Epub 2012 May 31. J Cardiol. 2012. PMID: 22658694 Free article.
Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study.
Yamazaki T, Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yokoi H, Yoshida M; Justification for Atherosclerosis Regression Treatment (JART) Investigators. Yamazaki T, et al. Int Heart J. 2013;54(1):33-9. doi: 10.1536/ihj.54.33. Int Heart J. 2013. PMID: 23428922 Free article. Clinical Trial.
174 results